SynthesisEndocrine, metabolic & immune disorders drug targets2026
Mendelian Randomization Studies of Major Depressive Disorder, Schizophrenia, Bipolar Disorder, and Cancers: A PRISMA Review and Meta-Analysis.
Elsa Vitale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.